Reversible RNA ADP-ribosylation on uracil bases
Nucleic Acids Research · 19.03.2026 · 54 (6)
DOI: 10.1093/nar/gkag289 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 31.03.2026. Verfasst von Yang Lu und 16 weiteren Autor:innen. Beteiligte Einrichtung: Sir William Dunn School of Pathology, University of Oxford, OxfordOX1 3RE, United Kingdom. Hauptthemen laut MEDLINE: ADP-Ribosylation, Uracil, Poly(ADP-ribose) Polymerases, RNA. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Biotechnology and Biological Sciences Research Council, Wellcome Trust, CRUK.
Abstract (Originalsprache)
ADP-ribosylation is a conserved modification that uses NAD+ as a co-substrate to regulate essential cellular processes, such as genome stability and transcription, with Poly(ADP-ribose) Polymerases (PARPs) serving as the major catalyzing enzymes in humans. Historically defined as a protein post-translational modification, ADP-ribosylation on nucleic acids has been increasingly recognized in recent years, particularly in bacterial systems, but remains poorly understood in higher organisms. Here, we identify human PARP10 as a candidate enzyme that ADP-ribosylates nucleic acid bases, showing apparent activity on uracil bases in RNA, and a relatively weaker activity toward thymine bases in DNA. Furthermore, we show that human TARG1, a neurodegenerative disorder-linked protein previously reported to hydrolyse thymine base ADP-ribosylation, also efficiently reverses uracil base ADP-ribosylation (U-ADPr). To improve the efficient characterization of the enzymes for U-ADPr reversal, we developed chemical probes. Using these probes, we demonstrated that human TARG1 and TARG1-like macrodomain proteins are the efficient hydrolases for U-ADPr reversal in humans, Drosophila melanogaster, and bacterial homologues. The widespread distribution of U-ADPr hydrolases among different organisms suggests the potential evolutionary conservation of U-ADPr as a biological signal.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Sir William Dunn School of Pathology, University of Oxford, OxfordOX1 3RE, United Kingdom.
- Carbohydrate-Based Drug Research Centre, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
- Zhongshan Institute for Drug Discovery, Chinese Academy of Sciences, Zhongshan 528400, China.
- School of Pharmacy, University of the Chinese Academy of Sciences, Beijing 100049, China.
- Department of Biomedicine, University of Bergen, Bergen5020, Norway.
- Health Science Centre, East China Normal University, Shanghai 200241, China.
ORCID-Profile: Herwig Schüler, Gyula Timinszky, Marcin J Suskiewicz, Vincent Aucagne, Qiang Liu, Ivan Ahel
Förderung
- Biotechnology and Biological Sciences Research Council
- Wellcome Trust
- CRUK
- Guy Newton Fund
- National Research Development and Innovation Office
- European Union's NextGeneration EU program
- Chinese Academy of Sciences
- National Natural Science Foundation of China
Zitieren
APA
Lu, Y., Tang, L., Strømland, Ø., Chatrin, C., Zhu, K., Munnur, D., Groslambert, J., Mikolčević, P., Schüler, H., Timinszky, G., Gabant, G., Suskiewicz, M. J., Mikoč, A., Aucagne, V., Ahel, D., Liu, Q., & Ahel, I. (2026). Reversible RNA ADP-ribosylation on uracil bases. Nucleic Acids Research, 54(6). https://doi.org/10.1093/nar/gkag289
Vancouver
Lu Y, Tang L, Strømland Ø, Chatrin C, Zhu K, Munnur D, et al. Reversible RNA ADP-ribosylation on uracil bases. Nucleic Acids Research. 2026;54(6). doi:10.1093/nar/gkag289
BibTeX
@article{Lu2026,
author = {Lu, Yang and Tang, Li and Strømland, Øyvind and Chatrin, Chatrin and Zhu, Kang and Munnur, Deeksha and Groslambert, Joséphine and Mikolčević, Petra and Schüler, Herwig and Timinszky, Gyula and Gabant, Guillaume and Suskiewicz, Marcin J and Mikoč, Andreja and Aucagne, Vincent and Ahel, Dragana and Liu, Qiang and Ahel, Ivan},
title = {Reversible RNA ADP-ribosylation on uracil bases},
journal = {Nucleic Acids Research},
year = {2026},
volume = {54},
number = {6},
doi = {10.1093/nar/gkag289}
}
EUVIMED